Aspen Aerogels (ASPN) Expected to Announce Earnings on Thursday

Aspen Aerogels (NYSE:ASPN) will likely be announcing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to post earnings of ($0.2275) per share and revenue of $42.4220 million for the quarter. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 6, 2026 at 8:30 AM ET.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Thursday, May 7th. The construction company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The business had revenue of $37.88 million for the quarter, compared to the consensus estimate of $36.58 million. During the same quarter in the prior year, the company earned ($0.06) EPS. Aspen Aerogels’s revenue was down 51.8% compared to the same quarter last year. On average, analysts expect Aspen Aerogels to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $4.09 on Thursday. The stock has a fifty day moving average of $5.61 and a 200 day moving average of $4.34. Aspen Aerogels has a 52 week low of $2.30 and a 52 week high of $9.78. The firm has a market capitalization of $339.13 million, a price-to-earnings ratio of -3.01 and a beta of 2.98. The company has a quick ratio of 2.54, a current ratio of 2.89 and a debt-to-equity ratio of 0.32.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Invesco Ltd. boosted its position in shares of Aspen Aerogels by 237.9% during the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock valued at $11,688,000 after purchasing an additional 2,907,558 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Aspen Aerogels by 105.4% in the second quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock worth $7,379,000 after purchasing an additional 639,753 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in Aspen Aerogels by 89.7% in the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after purchasing an additional 602,586 shares in the last quarter. State Street Corp lifted its position in Aspen Aerogels by 28.6% during the fourth quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock valued at $7,079,000 after buying an additional 556,833 shares during the period. Finally, Millennium Management LLC lifted its position in Aspen Aerogels by 59.6% during the third quarter. Millennium Management LLC now owns 1,447,517 shares of the construction company’s stock valued at $10,075,000 after buying an additional 540,772 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ASPN has been the topic of a number of research analyst reports. Roth Capital reissued a “buy” rating and set a $5.75 price objective on shares of Aspen Aerogels in a research report on Friday, May 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Wall Street Zen raised shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Barclays boosted their price target on shares of Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research report on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Aspen Aerogels has an average rating of “Hold” and an average target price of $5.19.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.